Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages

Journal of Molecular Medicine

Volumn 78, Issue 4, 2000, Pages 217-227

  Langer, Claus ^a   Huang, Yadong ^b   Cullen, Paul ^a   Wiesenhütter, Bernd ^a   Mahley, Robert W ^b   Assmann, Gerd ^a   Von Eckardstein, Arnold ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

Apolipoprotein A I; Arachidonic acid; Atherosclerosis; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN E; ARACHIDONIC ACID; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RECEPTOR BINDING; REGULATORY MECHANISM;

EID: 0033947205     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000096     Document Type: Article

References (57)

1. 1. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630
2. 2. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS (1994) The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 91:4431-4435
3. 3. Ghiselli E, Schaefer J, Gascon P, Brewer HB Jr (1981) Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 214:1239-1241
4. 4. Mabuchi H, Itoh H, Takeda M, Kajinami K, Wakasugi T, Koizumi J, Takeda R, Asagami C (1989) A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism 38:115-119
5. 5. Feussner G, Dobmeyer J, Grone HJ, Lohmer S, Wohlfeil S (1996) A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia. Am J Hum Genet 58:281-291
6. 6. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471
7. 7. Plump AS, Smith J, Hayek T, Aalto-Setulää K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353
8. 8. Mahley RW, Rall SC (1995) Type III Hyperlipoproteinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 7th edn. McGraw-Hill, New York, pp 1953-1971
9. 9. Mazzone T (1996) Apolipoprotein E secretion by macrophages: its potential functions. Curr Opin Lipidol 7:303-310
10. 10. Eckardstein A von (1996) Cholesterol efflux from macrophages and other cells. Curr Opin Lipidol 7:311-321
11. 11. Linton MF, Atkinson JB, Fazio S (1995) Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267:1034-1037
12. 12. Bolsvert WA, Spangenberg J, Curtiss LK (1995) Treatment of severe hyperlipidemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 96:1118-1124
13. 13. Bellosta S, Mahley RW, Sanan DA, Newland DL, Taylor JM, Pitas RE (1995) Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoproteinE-null mice. J Clin Invest 96:2170-2179
14. 14. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647-4652
15. 15. Basu SK, Ho Y, Brown MS, Bilheimer DW, Anderson RGW, Goldstein J (1982) Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem 257:9788-9795
16. 16. Basu S, Goldstein JL, Brown MS (1983) Independent pathways for secretion of free cholesterol and apolipoprotein E by macrophages. Science 219:871-873
17. 17. Dory L (1989) Synthesis and secretion of apo E in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux. J Lipid Res 30:809-816
18. 3. J Lipid Res 35:1345-1353
19. 19. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W (1994) Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J Biol Chem 269:24511-24518
20. 20. Zhang WY, Gaynor PM, Kruth HS (1996) Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 271:28641-28646
21. 21. Cullen P, Cignarella A, Brennhausen B, Mohr S, Assmann G, von Eckardstein A (1998) Phenotype-dependent differences in apolipoprotein E metabolism and cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest 101:1670-1677
22. 22. Hayek T, Oiknine J, Brook JG, Aviram M (1994) Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apoE knock out transgenic mice. Biochem Biophys Res Commun 205:1072-1078
23. 23. Huang Y, Langer C, Raabe M, Wiesenhütter B, Wu S, Seedorf U, Maeda N, Assmann G, von Eckardstein A (1997) Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I, and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 17:2010-2019
24. 24. Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley RW, Assmann G, von Eckardstein A (1997) Low-dose expression of a human apolipoproteinE transgene in macrophages restores cholesterol efflux capacity of apolipoproteinE-deficient mouse plasma. Proc Natl Acad Sci USA 95:7585-7590
25. 25. Koo C, Innerarity TL, Mahley RW (1985) Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol enriched and receptor-active high density lipoproteins. J Biol Chem 260:11934-11943
26. 26. Cullen P, Fobker M, Tegelkamp K, Meyer K, Kannenberg F, Cignarella A, Benninghoven A, Assmann G (1997) An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl ester species by means of secondary ion mass spectrometry. J Lipid Res 38:401-409
27. 27. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins inhuman serum. J Clin Invest 34:1345-1353
28. 28. Brown MS, Ho YK, Goldstein JL (1980) The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and reesterification of cytoplasmic cholesteryl esters. J Biol Chem 255:9344-9352
29. 29. Mezdour H, Clavey V, Kora I, Koffigan M, Barkia A, Fruchart JC (1987) Anion-exchange fast protein liquid Chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma. J Chromatogr 414:35-45
30. 30. von Eckardstein A, Walter M, Benninghoven A, Assmann G (1991) Site specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity in apolipoproteins A-I, C-II, and C-III. J Lipid Res 32:1465-1476
31. 31. Dong LM, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053-19057
32. 32. Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA (1994) Human apolipoproteinE: role for arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269:22358-22365
33. 33. Piedrahita SH, Zhang J, Hagamann PM, Oliver N, Maeda A (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89:4471-4475
34. 34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
35. 35. Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-260
36. 36. Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 266:497-509
37. 37. Rothblat GH, de la Llera Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC (1999) Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40:781-796
38. 38. Fielding CJ, Fielding PE (1997) Intracellular cholesterol transport. J Lipid Res 38:1503-1521
39. 39. Oram JF, Yokoyama S (1997) Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 37:2473-2491
40. 40. Chilton FH, Fonteh AN, Surette ME, Triggiani M, Winkler JD (1996) Control of arachidonate levels within inflammatory cells. Biochim Biophys Acta 1299:1-15
41. 41. Maclouf J, Folco G, Patrono C (1998) Eicosanoids and Isoeicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease. Thromb Haemost 79:691-705
42. 42. Miyazaki A, Rahim AT, Ohta T, Morino Y, Horiuchi S (1992) High density lipoprotein mediates selective reduction in cholesteryl esters from macrophage foam cells. Biochim Biophys Acta 1126:73-80
43. 43. Bernard DW, Rodriguez A, Rothblat GH, Glick JM (1990) Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. Arterioscler Thromb 10:135-144
44. 44. Dory, L (1989) Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux. J Lipid Res 30:809-816
45. 45. Herscovitz H, Gantz D, Terycak AM, Zannis VI, Small DM (1992) Expression of human apolipoprotein E but not apolipoprotein A-I by mouse c127 cells is associated with increased secretion of lipids in the form of vesicles and discs. J Lipid Res 33:791-803
46. 46. Hara H, Yokoyama S (1991) Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 266:3080-3086
47. 47. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah AM, Segrest JP, Phillips MC, Rothblat GH (1995) Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 34:7955-7965
48. ++ antagonists and ACAT-inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism. Arterioscler Thromb 8:46-56
49. 49. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 271:30647-30655
50. 50. Boisvert WA, Black AS, Curtiss LK (1999) ApoA-I reduces free cholesterol accumulation in atherosclerotic lesions of apoE deficient mice transplanted with apoE-expressing macrophages. Arterioscler Thromb Vasc Biol 19:525-530
51. 51. Deng J, Rudick V, Rudick M, Dory L (1997) Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. J Lipid Res 38:217-227
52. 52. Lucas M, Mazzone T (1996) Cell-surface proteoglycans modulate net synthesis and secretion of macrophage apoE. J Biol Chem 271:13454-13460
53. 53. Bielicki JK, McCall MR, Forte TM (1999) Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage like foam cells. J Lipid Res 40:85-92
54. 54. Lin CY, Lucas M, Mazzone T (1998) Endogenous apoE expression modulates HDL3 binding to macrophages. J Lipid Res 39:293-301
55. 55. Riddell DR, Graham A, Owen JS (1997) Apolipoprotein E inhibits platelet aggregation through the L-arginine: nitric oxide pathway. Implications for vascular disease. J Biol Chem 272:89-95
56. 56. Ishigami M, Swertfeger DK, Granholm NA, Hui D (1998) Apolipoprotein E inhibits platelet derived growth factor induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 273:20156-20161
57. 57. Kuipers F, Jong MC, Lin Y, van Eck M, Havinga R, Bloks V, Verkade HJ, Hofker MH, Moshage H, van Berkel TJC, Von RJ, Havekes LM (1997) Impaired secretion of very low density lipoprotein - triglycerides by apolipoproteinE-deficient mouse hepatocytes. J Clin Invest 100:2915-2922